Franklin Resources’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.53M | Buy |
393,885
+69,490
| +21% | +$623K | ﹤0.01% | 1491 |
|
|
2025
Q1 | $2.43M | Buy |
324,395
+62,013
| +24% | +$465K | ﹤0.01% | 1609 |
|
|
2024
Q4 | $1.97M | Sell |
262,382
-1,366
| -0.5% | -$10.3K | ﹤0.01% | 1733 |
|
|
2024
Q3 | $1.97M | Buy |
263,748
+168,790
| +178% | +$1.26M | ﹤0.01% | 1746 |
|
|
2024
Q2 | $587K | Buy |
94,958
+18,031
| +23% | +$111K | ﹤0.01% | 2155 |
|
|
2024
Q1 | $391K | Buy |
+76,927
| New | +$391K | ﹤0.01% | 2352 |
|
|
2023
Q1 | – | Sell |
-14,414
| Closed | -$165K | – | 2316 |
|
|
2022
Q4 | $165K | Buy |
+14,414
| New | +$165K | ﹤0.01% | 2036 |
|
|
2016
Q2 | – | Sell |
-1,658,217
| Closed | -$4.69M | – | 1499 |
|
|
2016
Q1 | $4.69M | Hold |
1,658,217
| – | – | ﹤0.01% | 1112 |
|
|
2015
Q4 | $17.1M | Buy |
1,658,217
+245,400
| +17% | +$2.53M | 0.01% | 887 |
|
|
2015
Q3 | $16.1M | Buy |
1,412,817
+664,098
| +89% | +$7.57M | 0.01% | 907 |
|
|
2015
Q2 | $11.2M | Buy |
+748,719
| New | +$11.2M | 0.01% | 1014 |
|